MoonLake Immunotherapeutics (NASDAQ:MLTX) Trading Down 1.9%
MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) shares traded down 1.9% during trading on Tuesday . The company traded as low as $35.78 and last traded at $35.97. 182,308 shares changed hands during mid-day trading, a decline of 64% from the average session volume of 512,274 shares. The stock had previously closed at $36.67. Analysts […]
More Stories
US Issues License for Oil and Gas Exploration in Venezuela
By Jill McLaughlin The U.S. Treasury Department issued a general license on Feb. 10 authorizing the exploration, development, and production...
Small Business Administration Suspends 111,620 California Borrowers Suspected of $8.6 Billion Fraud
By Naveen Athrappully The Small Business Administration (SBA) has suspended 111,620 California borrowers suspected of committing fraudulent activity related to...
Freight Data Indicate Early US Industrial Rebound as Midwest Truck Volumes Jump
By Tom Ozimek U.S. freight markets are showing signs of a shift toward domestically driven industrial activity, with truckload volumes...
Musk Offers Legal Fees for Anyone Sued Who ‘Speaks the Truth’ About Epstein
By Rachel Roberts Tech billionaire Elon Musk said he will pay the legal fees of anyone who speaks out about...
FBI Releases New Images of Potential Suspect in Nancy Guthrie Kidnapping
By Zachary Stieber The FBI on Feb. 10 released new images and videos showing a person outside the home of...
UK PM Starmer’s Communications Director Quits Over Mandelson–Epstein Scandal
By Owen Evans British Prime Minister Keir Starmer’s communications director, Tim Allan, resigned on Feb. 9, a day after Chief...